Get started
Author

Jasmin Asberger

Observed names: J Asberger, J. Asberger
ORCID: 0000-0003-2226-769X
Observed ORCID: 0000-0003-2226-769X
OpenAlex ID: A5077912354
Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment
2017 · Elena Martinez-Garcia, Antoine Lesur, et al. · Clinical Cancer Research · 69
Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
2019 · Andrea Ritter, Marc Hirschfeld, et al. · International Journal of Oncology · 41
PDF
Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer
2024 · Stephanie W. Vrede, Willem Jan Van Weelden, et al. · Gynecologic Oncology · 39
PDF
Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer
2020 · Andrea Ritter, Marc Hirschfeld, et al. · Cancer Biomarkers · 37
PDF
Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer
2022 · Stephanie W. Vrede, Jenneke Kasius, et al. · JAMA Network Open · 35
PDF
BMI and Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Study and Meta-Analysis
2016 · Thalia Erbes, Elmar Stickeler, et al. · Clinical Breast Cancer · 31
Structured reporting ensures complete content and quick detection of essential data in pathology reports of oncological breast resection specimens
2016 · Konrad Aumann, Kathrin Niermann, et al. · Breast Cancer Research and Treatment · 27
Gastrin-Releasing Peptide Receptor Antagonist [68Ga]RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast Cancer
2021 · Kerstin Michalski, Lars Kemna, et al. · Cancers · 21
PDF
Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case–control study
2021 · Kai Berner, Marc Hirschfeld, et al. · Archives of Gynecology and Obstetrics · 16
PDF
Association between gastrin-releasing peptide receptor expression as assessed with [68Ga]Ga-RM2 PET/CT and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancer
2020 · Kerstin Michalski, Christian Stoykow, et al. · Nuclear Medicine and Biology · 14
Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in�vitro
2020 · Marc Hirschfeld, Isabel Ge, et al. · Molecular Medicine Reports · 10
PDF
Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro
2021 · Anna-Lena Klauser, Marc Hirschfeld, et al. · Breast Cancer Targets and Therapy · 8
PDF
Endoxifen and fulvestrant regulate estrogen-receptor α and related DEADbox proteins
2020 · Jasmin Asberger, Thalia Erbes, et al. · Endocrine Connections · 7
PDF
ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment
2025 · Marike S. Lombaers, Casper Reijnen, et al. · European Journal of Cancer · 6
Real-World Data Analysis of CDK4/6 Inhibitor Therapy—A Patient-Centric Single Center Study
2024 · Isabell Ge, Kai Berner, et al. · Cancers · 6
PDF
Surgical stage in the era of molecular profiling of endometrial cancer
2025 · J.C. Kasius, W. Kildal, et al. · European Journal of Cancer · 4
PDF
Improving pre-operative binary grading: relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinoma
2025 · Puk Meijs-Hermanns, Henrica M.J. Werner, et al. · International Journal of Gynecological Cancer · 3
PDF
Treatment of Cesarean Scar and Cervical Pregnancies Using the Ovum Aspiration Set for Intrachorial Methotrexate Injection as a Conservative, Fertility-Preserving Procedure
2023 · Isabell Ge, Carmen Geißler, et al. · Medicina · 3
PDF
[68Ga]Ga-RM2 PET/CT reveals small distant metastases not detected by conventional imaging in primary estrogen receptor-positive breast cancer
2023 · Kerstin Michalski, Katharina Müller-Peltzer, et al. · Archives of Gynecology and Obstetrics · 3
PDF
Long non‑coding RNA signatures in breast cancer: Properties as biomarkers?
2025 · Jasmin Asberger, Isabell Ge, et al. · Experimental and Therapeutic Medicine · 2
PDF
In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer
2023 · Jasmin Asberger, Kai Berner, et al. · Biomedicines · 2
PDF
Menopause im Mund: Wie Hormone die Mundgesundheit beeinflussen können
2026 · Claire Osterloh, Jasmin Asberger · Journal für Gynäkologische Endokrinologie/Schweiz
PDF
The impact of the patient macroenvironment on molecular subgroups in endometrial cancer
2026 · Henrica M. J. Werner, Frederiek A. H. van Dijk, et al. · Cancer
Prediction of locoregional recurrence in early-stage endometrial cancer using bayesian networks (endorisk-predict)
2026 · Rosewinthe T.C.I.M. Wibier, Johanna M.A. Pijnenborg, et al. · International Journal of Gynecological Cancer
PDF
Selective POLE mutation analysis in endometrial cancer; to reduce healthcare cost
2026 · Ruben Koek, Casper Reijnen, et al. · International Journal of Gynecological Cancer
Works count: 51
Citation count: 380
H-index: 10
I10-index: 11
Year
Topic
Type